MedPath

Reducing Wrinkles Around the Eyes Using the Ulthera® System

Not Applicable
Completed
Conditions
Periorbital Wrinkles
Interventions
Device: Ulthera® System treatment
Registration Number
NCT01368900
Lead Sponsor
Ulthera, Inc
Brief Summary

The purpose of this prospective, multi-center, single treatment study is to evaluate the clinical outcomes associated with the non-invasive treatment to reduce wrinkles around the eyes utilizing the Ulthera® System to deliver focused ultrasound energy below the surface of the skin.

Detailed Description

The primary objective of this clinical trial is to demonstrate the effectiveness of the Ulthera® System for non-invasive treatment to reduce wrinkles around the eyes.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
68
Inclusion Criteria
  • Male or female, aged 30 to 65 years.
  • Subject in good health.
  • Mild to moderate rhytids in the periorbital region.
  • Willingness and ability to comply with protocol requirements and return for follow-up visits.
  • Not pregnant.
  • Provide written informed consent and HIPAA authorization.
Exclusion Criteria
  • Presence of an active systemic or local skin disease that may affect wound healing.
  • Severe solar elastosis.
  • Excessive subcutaneous fat in the face.
  • Deep wrinkles, numerous lines, with or without redundant skin in the area to be treated.
  • Excessive hooding, with or without redundant skin, in the areas to be treated.
  • Significant scarring in areas to be treated.
  • Significant open facial wounds or lesions.
  • Severe or cystic acne on the face.
  • Presence of a metal stent or implant in the facial area to be treated.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Ulthera System TreatmentUlthera® System treatmentUlthera treatment to the upper face.
Primary Outcome Measures
NameTimeMethod
Overall Improvement in Periorbital Wrinkles and Rhytids Around the Eyes90 days post-treatment

Improvement in periorbital skin laxity and rhytids as determined by masked assessor review of photographs at 90days post-treatment compared to baseline.

Secondary Outcome Measures
NameTimeMethod
Improvement in Periorbital Wrinkles and Rhytids Around the Eyes at 90 Days Post-treatment90 days post-treatment

At 90 days post-treatment, each site investigator and each subject completed a Global Aesthetic Improvement Scale (GAIS), comparing with pre-treatment photos. The GAIS is 5-point scale (1-5) describing an overall assessment as follows:

1. = Very Much Improved

2. = Much Improved

3. = Improved

4. = No Change

5. = Worse

"Any Improvement" includes subjects assessed in categories 1-3.

Improvement in Periorbital Wrinkles and Rhytids Around the Eyes at 60 Days Post-treatment60 days post-treatment

At 60 days post-treatment, each site investigator and each subject completed a Global Aesthetic Improvement Scale (GAIS), comparing with pre-treatment photos. The GAIS is 5-point scale (1-5) describing an overall assessment as follows:

1. = Very Much Improved

2. = Much Improved

3. = Improved

4. = No Change

5. = Worse

"Any Improvement" includes subjects assessed in categories 1-3.

Patient Satisfaction Questionnaire at 180 Days Post-treatment180 days post-treatment

Subject satisfaction determined by scores on a patient satisfaction questionnaire at 180 days post-treatment.

Patient Satisfaction Questionnaire 90 Days Post-treatment90 days post-treatment

Subject satisfaction determined by scores on a patient satisfaction questionnaire at 90 days post-treatment.

Improvement in Periorbital Wrinkles and Rhytids Around the Eyes at 180 Days Post-treatment180 days post-treatment

At 180 days post-treatment, each site investigator and each subject completed a Global Aesthetic Improvement Scale (GAIS), comparing with pre-treatment photos. The GAIS is 5-point scale (1-5) describing an overall assessment as follows:

1. = Very Much Improved

2. = Much Improved

3. = Improved

4. = No Change

5. = Worse

"Any Improvement" includes subjects assessed in categories 1-3.

Trial Locations

Locations (2)

MD Laser Skin & Vein Institute

🇺🇸

Hunt Valley, Maryland, United States

The Nashville Centre for Laser and Facial Surgery

🇺🇸

Nashville, Tennessee, United States

© Copyright 2025. All Rights Reserved by MedPath